Clarity Pharmaceuticals (ASX: CU6) – webinar presentation
Dr Alan Taylor – Executive Chairperson – Clarity’s mission is to develop next-generation radiopharmaceutical products that improve treatment outcomes for children and adults with cancer.
Read More